Cleo Diagnostics Ltd

NEW
ASX:COV (Australia)  
A$ 0.34 -0.010 (-2.82%) Jul 21
At Loss
P/B:
5.39
Market Cap:
A$ 48.67M ($ 34.10M)
Enterprise V:
A$ 39.25M ($ 27.49M)
Volume:
41.91K
Avg Vol (2M):
182.48K
Trade In:
Volume:
41.91K
At Loss
Avg Vol (2M):
182.48K

Business Description

Description
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.89
Interest Coverage
No Debt
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
9.94
9-Day RSI
18.03
14-Day RSI
24.48
3-1 Month Momentum %
-22.22
6-1 Month Momentum %
-37.97
12-1 Month Momentum %
28.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
8.46
Quick Ratio
8.46
Cash Ratio
8.3

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-9.39
Name Current Vs Industry Vs History
ROE %
-54.73
ROA %
-48.8
ROIC %
-1410.81
ROC (Joel Greenblatt) %
-23032.58
ROCE %
-92.75

Financials

ASX:COV's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Cleo Diagnostics Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.029
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 64.2
14-Day RSI 24.48
14-Day ATR (A$) 0.033811
20-Day SMA (A$) 0.466
12-1 Month Momentum % 28.95
52-Week Range (A$) 0.335 - 0.9
Shares Outstanding (Mil) 137.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cleo Diagnostics Ltd Filings

Filing Date Document Date Form
No Filing Data

Cleo Diagnostics Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Cleo Diagnostics Ltd Frequently Asked Questions

What is Cleo Diagnostics Ltd(ASX:COV)'s stock price today?
The current price of ASX:COV is A$0.35. The 52 week high of ASX:COV is A$0.90 and 52 week low is A$0.34.
When is next earnings date of Cleo Diagnostics Ltd(ASX:COV)?
The next earnings date of Cleo Diagnostics Ltd(ASX:COV) is .
Does Cleo Diagnostics Ltd(ASX:COV) pay dividends? If so, how much?
Cleo Diagnostics Ltd(ASX:COV) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Cleo Diagnostics Ltd

No articles.